Inhibitors of PI3Kβ as Potential Treatment for Cancer

被引：1
|
作者：
Abdel-Magid, Ahmed F. [1 ]
机构：
[1] Therachem Res Medilab India Pvt Ltd, Jaipur, Rajasthan, India
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2013年 / 4卷 / 09期
关键词：
D O I：
10.1021/ml400274v
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：815 / 816
页数：2
相关论文
共 50 条
  • [21] PI3K: A potential therapeutic target for cancer
    Chen, Yingwei
    Wang, Bao-Can
    Xiao, Yongtao
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (07) : 2818 - 2821
  • [22] New Horizons in Cancer Treatment: A Closer Look at Novel PI3Kα Inhibitors
    Kargbo, Robert B. B.
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (09): : 1138 - 1140
  • [23] Treatment of Breast Cancer Using Multistage Delivery of PI3K/mTOR Inhibitors
    Blanco, E.
    Sangai, T.
    Martinez, J. O.
    Meric-Bernstam, F.
    Ferrari, M.
    CANCER RESEARCH, 2010, 70
  • [24] Identification and development of inhibitors of PI3K and related protein kinases for cancer treatment
    Maira, Michel
    Stauffer, Frederic
    Furet, Pascal
    Capraro, Hans-Georg
    Holzer, Philipp
    Garcia-Echeverria, Carlos
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 772 - 772
  • [25] PI3Kδ inhibitors for the treatment of cancer: a patent review (2015-present)
    Feng, Yifan
    Cu, Xiaochuan
    Xin, Minhang
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2019, 29 (12) : 925 - 941
  • [26] Phytochemicals as PI3K/Akt/mTOR Inhibitors and Their Role in Breast Cancer Treatment
    Narayanankutty, Arunaksharan
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2020, 15 (03) : 188 - 199
  • [27] Rationale-based therapeutic combinations with PI3K inhibitors in cancer treatment
    Castely, Pau
    Toskay, Eneda
    Zumsteg, Zachary S.
    Carmona, F. Javier
    Elkabets, Moshe
    Bosch, Ana
    Scaltriti, Maurizio
    MOLECULAR & CELLULAR ONCOLOGY, 2014, 1 (03)
  • [28] Discovery of novel and potent PARP/PI3K dual inhibitors for the treatment of cancer
    Wu, Zhengyang
    Bai, Ying
    Jin, Jiaming
    Jiang, Teng
    Shen, Hui
    Ju, Qiurong
    Zhu, Qihua
    Xu, Yungen
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 217
  • [29] The role of PI3K inhibitors in the treatment of malignant lymphomas
    Berning, Philipp
    Lenz, Georg
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 517 - 527
  • [30] PI3K Isoform-Selective Inhibitors in Cancer
    Duncan, Leslie
    Shay, Chloe
    Teng, Yong
    SINGLE-CELL SEQUENCING AND METHYLATION: METHODS AND CLINICAL APPLICATIONS, 2020, 1255 : 165 - 173
12345